226 related articles for article (PubMed ID: 34387101)
1. Effect of Heart Rate Variabilities on Outcome After Acute Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH-2.
Miwa K; Koga M; Fukuda-Doi M; Yamamoto H; Tanaka K; Yoshimura S; Ihara M; Qureshi AI; Toyoda K
J Am Heart Assoc; 2021 Aug; 10(16):e020364. PubMed ID: 34387101
[TBL] [Abstract][Full Text] [Related]
2. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion.
Morotti A; Boulouis G; Romero JM; Brouwers HB; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
Neurology; 2017 Aug; 89(6):548-554. PubMed ID: 28701501
[TBL] [Abstract][Full Text] [Related]
4. Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome.
Rodriguez-Luna D; Pancorbo O; Llull L; Silva Y; Prats-Sanchez L; Muchada M; Rudilosso S; Terceño M; Ramos-Pachón A; Hernandez Guillamon M; Coscojuela P; Blasco J; Perez-Hoyos S; Chamorro A; Molina CA;
Neurology; 2024 May; 102(9):e209244. PubMed ID: 38598746
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-intracerebral hemorrhage study.
Tanaka E; Koga M; Kobayashi J; Kario K; Kamiyama K; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Todo K; Kimura K; Okada Y; Okata T; Arihiro S; Sato S; Yamagami H; Nagatsuka K; Minematsu K; Toyoda K
Stroke; 2014 Aug; 45(8):2275-9. PubMed ID: 24968929
[TBL] [Abstract][Full Text] [Related]
6. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
Law ZK; Desborough M; Roberts I; Al-Shahi Salman R; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
J Am Heart Assoc; 2021 Feb; 10(5):e019130. PubMed ID: 33586453
[TBL] [Abstract][Full Text] [Related]
8. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial.
Okazaki S; Yamamoto H; Foster LD; Fukuda-Doi M; Koga M; Ihara M; Toyoda K; Palesch YY; Qureshi AI
Cerebrovasc Dis; 2020; 49(1):26-31. PubMed ID: 32045911
[TBL] [Abstract][Full Text] [Related]
9. Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage.
Law ZK; Ali A; Krishnan K; Bischoff A; Appleton JP; Scutt P; Woodhouse L; Pszczolkowski S; Cala LA; Dineen RA; England TJ; Ozturk S; Roffe C; Bereczki D; Ciccone A; Christensen H; Ovesen C; Bath PM; Sprigg N;
Stroke; 2020 Jan; 51(1):121-128. PubMed ID: 31735141
[TBL] [Abstract][Full Text] [Related]
10. Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies.
Qiu M; Sato S; Zheng D; Wang X; Carcel C; Hirakawa Y; Sandset EC; Delcourt C; Arima H; Wang J; Chalmers J; Anderson CS;
Stroke; 2016 Jun; 47(6):1479-85. PubMed ID: 27165954
[TBL] [Abstract][Full Text] [Related]
11. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.
Sakamoto Y; Koga M; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Arihiro S; Sato S; Kobayashi J; Tanaka E; Nagatsuka K; Minematsu K; Toyoda K;
Stroke; 2013 Jul; 44(7):1846-51. PubMed ID: 23704107
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage.
Toyoda K; Koga M; Yamamoto H; Foster L; Palesch YY; Wang Y; Sakai N; Hara T; Hsu CY; Itabashi R; Sato S; Fukuda-Doi M; Steiner T; Yoon BW; Hanley DF; Qureshi AI;
Ann Neurol; 2019 Jan; 85(1):105-113. PubMed ID: 30421455
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
Qureshi AI; Palesch YY
Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2.
Fukuda-Doi M; Yamamoto H; Koga M; Palesch YY; Durkalski-Mauldin VL; Qureshi AI; Yoshimura S; Okazaki S; Miwa K; Okada Y; Ueda T; Okuda S; Nakahara J; Suzuki N; Toyoda K
Stroke; 2020 Aug; 51(8):2282-2286. PubMed ID: 32623977
[TBL] [Abstract][Full Text] [Related]
15. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
[TBL] [Abstract][Full Text] [Related]
16. Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.
Kobayashi J; Koga M; Tanaka E; Okada Y; Kimura K; Yamagami H; Okuda S; Hasegawa Y; Shiokawa Y; Furui E; Nakagawara J; Kario K; Okata T; Arihiro S; Sato S; Nagatsuka K; Minematsu K; Toyoda K;
Stroke; 2014 Mar; 45(3):868-70. PubMed ID: 24425118
[TBL] [Abstract][Full Text] [Related]
17. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
[TBL] [Abstract][Full Text] [Related]
18. Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments.
Yogendrakumar V; Ramsay T; Menon BK; Qureshi AI; Saver JL; Dowlatshahi D
Neurology; 2021 Aug; 97(8):e755-e764. PubMed ID: 34144995
[TBL] [Abstract][Full Text] [Related]
19. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
[TBL] [Abstract][Full Text] [Related]
20. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
